| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0072 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0058 | 1 |